We are closed on Thursday 19th November 2026 1pm-6:30pm for staff training. We will reopen Friday 20th November 2026 at 8 am, phone lines 8:30 am. During the closure our e-consult will be switched off and our phones and emails will not be monitored. 

Read more
icon

Patient News

15 Sep, 2025
NHS CERVICAL SMEAR PROGRAMME - NHS APP

From September, NHS plans to start sending results from the NHS Cervical Screening Programme, utilising the NHS App.

In September, those who have a negative test result will be notified of this by an NHS App message. It will also appear as an NHS App notification. If the NHS App message isn’t read within 72 hours, a letter will be sent as a failsafe.

Abnormal result letters will continue for the time being to be delivered by post.

This change follows the successful roll out of digital invitations and reminders in June 2025, where since the launch, 9 out of every 10 invitations are being sent digitally, with the remainder being sent by post.

From September, NHS plans to start sending results from the NHS Cervical Screening Programme, utilising the NHS App.

In September, those who have a negative test result will be notified of this by an NHS App message. It will also appear as an NHS App notification. If the NHS App message isn’t read within 72 hours, a letter will be sent as a failsafe.

Abnormal result letters will continue for the time being to be delivered by post.

This change follows the successful roll out of digital invitations and reminders in June 2025, where since the launch, 9 out of every 10 invitations are being sent digitally, with the remainder being sent by post.

Mounjaro (Tirzepatide) Injections

You may have seen information in the media recently about the release of NICE guidance (TA1026) Mounjaro (Tirzepatide) injections for managing Obesity and Overweight in Adults, as well as its use to treat Type 2 Diabetes.

From 23rd June 2025 GPs will be able to prescribe Mounjaro on the NHS to certain cohorts of patients that meet strict eligiblity criteria.

A BMI of 40 or higher, or 37.5 or higher if from South Asian, Chinese, other Asian, Middle Eastern, Black African or African-Caribbean ethnic backgrounds AND

At least 4 of the following comorbidities:

  • Hypertension and on treatment for blood pressure
  • Dyslipidaemia (high cholesterol) or on cholesterol treatment "statins"
  • Obstructive Sleep Apnoea
  • Cardiovascular disease (Heart conditions, Angina, Stroke)
  • Type 2 diabetes

If you feel that you meet the criteria, the first step is to complete an eConsult to provide an up to date height and weight, so that we can calculate your BMI. 

We will then check your other conditions (comorbidities) to confirm whether or not you meet the criteria. 

If your BMI and comorbidities suggest you may be suitable for Mounjaro, we will then contact you to book an appointment with our HCA. 

Please note that you will also be weighed by the practice at this appointment. 

You will also be required to engage in a weight management support programme which will be commissioned nationally by NHS England to support patients being prescribed Mounjaro. This is a condition of prescribing set by NHS England.  

There are a number of local weight management services currently available for people living with obesity or overweight,  and we are happy to discuss these and support you with your weight management goals.

You may have seen information in the media recently about the release of NICE guidance (TA1026) Mounjaro (Tirzepatide) injections for managing Obesity and Overweight in Adults, as well as its use to treat Type 2 Diabetes.

From 23rd June 2025 GPs will be able to prescribe Mounjaro on the NHS to certain cohorts of patients that meet strict eligiblity criteria.

A BMI of 40 or higher, or 37.5 or higher if from South Asian, Chinese, other Asian, Middle Eastern, Black African or African-Caribbean ethnic backgrounds AND

At least 4 of the following comorbidities:

  • Hypertension and on treatment for blood pressure
  • Dyslipidaemia (high cholesterol) or on cholesterol treatment "statins"
  • Obstructive Sleep Apnoea
  • Cardiovascular disease (Heart conditions, Angina, Stroke)
  • Type 2 diabetes

If you feel that you meet the criteria, the first step is to complete an eConsult to provide an up to date height and weight, so that we can calculate your BMI. 

We will then check your other conditions (comorbidities) to confirm whether or not you meet the criteria. 

If your BMI and comorbidities suggest you may be suitable for Mounjaro, we will then contact you to book an appointment with our HCA. 

Please note that you will also be weighed by the practice at this appointment. 

You will also be required to engage in a weight management support programme which will be commissioned nationally by NHS England to support patients being prescribed Mounjaro. This is a condition of prescribing set by NHS England.  

There are a number of local weight management services currently available for people living with obesity or overweight,  and we are happy to discuss these and support you with your weight management goals.

23 Jun, 2025
11 Apr, 2025
image
Would you like to join our PPG?

The Patient Participation Group (PPG) is made up of volunteer patients, the practice manager, and a GP.

It is open to all patients registered at the practice and serves as a valuable platform for patients to share their views, highlight what matters most to them, and work collaboratively with the practice to identify solutions and improvements.

Please contact the reception or you can also submit our online form.

The Patient Participation Group (PPG) is made up of volunteer patients, the practice manager, and a GP.

It is open to all patients registered at the practice and serves as a valuable platform for patients to share their views, highlight what matters most to them, and work collaboratively with the practice to identify solutions and improvements.

Please contact the reception or you can also submit our online form.

Related Information